| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.805 | 3.455 | 3.827 | 2.788 | 1.443 | 1.779 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 3.805 | 3.455 | 3.827 | 2.789 | 1.443 | 1.779 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.264 | 1.658 | 3.775 | 1.928 | 1.724 | 2.838 | 162 | 267 | 597 | 121 |
| Gross Profit/Loss - EUR | 2.541 | 1.797 | 52 | 861 | -282 | -1.059 | -162 | -267 | -597 | -121 |
| Net Profit/Loss - EUR | 2.427 | 1.693 | -63 | 777 | -325 | -1.113 | -162 | -267 | -597 | -121 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Diabet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.257 | 4.140 | 4.381 | 4.792 | 4.393 | 3.401 | 3.043 | 2.767 | 2.161 | 2.028 |
| Inventories | 195 | 57 | 73 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 |
| Cash | 3.063 | 4.083 | 4.308 | 4.792 | 4.393 | 3.401 | 3.043 | 2.764 | 2.158 | 2.025 |
| Shareholders Funds | 2.472 | 4.140 | 4.007 | 4.711 | 4.295 | 3.101 | 2.870 | 2.612 | 2.007 | 1.875 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 786 | 0 | 374 | 81 | 98 | 300 | 172 | 154 | 153 | 153 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1071 - 1071" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Diabet S.r.l.